Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 141.61
0.79 %
$ 20.7 B
Market Cap
12.67
P/E
BIIB - SHORT-TERM DEBT
Short-term Debt BIIB - Biogen Inc.
1.75 B
LAST VALUE
324.14%
2 YEAR CAGR
2.19%
5 YEAR CAGR
88.21%
10 YEAR CAGR